Scott Schoenhaus
Stock Analyst at Keybanc
(2.03)
# 2,847
Out of 4,842 analysts
102
Total ratings
34.09%
Success rate
-5.82%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Maintains: Overweight | $30 → $32 | $21.40 | +49.53% | 5 | Apr 16, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $32 → $40 | $32.24 | +24.07% | 3 | Apr 16, 2025 | |
| PHR Phreesia | Maintains: Overweight | $30 → $28 | $24.29 | +15.27% | 7 | Apr 16, 2025 | |
| ODD Oddity Tech | Maintains: Overweight | $52 → $50 | $72.48 | -31.02% | 3 | Apr 16, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $100 | $101.42 | -1.40% | 5 | Apr 16, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $7 → $5 | $3.64 | +37.36% | 6 | Apr 16, 2025 | |
| DOCS Doximity | Maintains: Overweight | $83 → $70 | $51.96 | +34.72% | 3 | Apr 16, 2025 | |
| CERT Certara | Maintains: Overweight | $15 → $18 | $11.45 | +57.21% | 4 | Apr 16, 2025 | |
| ABCL AbCellera Biologics | Maintains: Overweight | $4 → $5 | $2.05 | +144.50% | 5 | Apr 16, 2025 | |
| ABSI Absci | Maintains: Overweight | $5 → $9 | $2.75 | +227.87% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $255 | $281.18 | -9.31% | 15 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $10 | $4.50 | +122.22% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $7 | $11.36 | -38.38% | 3 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $6 | $3.79 | +58.31% | 5 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4.5 | $3.30 | +36.36% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $11 | $5.52 | +99.46% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $21.60 | - | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $29.49 | - | 8 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $7.01 | - | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $180 → $250 | $140.22 | +78.29% | 2 | Apr 16, 2021 |
Schrödinger
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $32
Current: $21.40
Upside: +49.53%
Simulations Plus
Apr 16, 2025
Maintains: Overweight
Price Target: $32 → $40
Current: $32.24
Upside: +24.07%
Phreesia
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $28
Current: $24.29
Upside: +15.27%
Oddity Tech
Apr 16, 2025
Maintains: Overweight
Price Target: $52 → $50
Current: $72.48
Upside: -31.02%
HealthEquity
Apr 16, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $101.42
Upside: -1.40%
Health Catalyst
Apr 16, 2025
Maintains: Overweight
Price Target: $7 → $5
Current: $3.64
Upside: +37.36%
Doximity
Apr 16, 2025
Maintains: Overweight
Price Target: $83 → $70
Current: $51.96
Upside: +34.72%
Certara
Apr 16, 2025
Maintains: Overweight
Price Target: $15 → $18
Current: $11.45
Upside: +57.21%
AbCellera Biologics
Apr 16, 2025
Maintains: Overweight
Price Target: $4 → $5
Current: $2.05
Upside: +144.50%
Absci
Apr 16, 2025
Maintains: Overweight
Price Target: $5 → $9
Current: $2.75
Upside: +227.87%
Jan 8, 2025
Maintains: Overweight
Price Target: $285 → $255
Current: $281.18
Upside: -9.31%
Jan 8, 2025
Maintains: Overweight
Price Target: $12 → $10
Current: $4.50
Upside: +122.22%
Jan 8, 2025
Maintains: Overweight
Price Target: $10 → $7
Current: $11.36
Upside: -38.38%
Jan 8, 2025
Maintains: Overweight
Price Target: $7 → $6
Current: $3.79
Upside: +58.31%
Dec 9, 2024
Initiates: Overweight
Price Target: $4.5
Current: $3.30
Upside: +36.36%
Nov 13, 2024
Maintains: Overweight
Price Target: $10 → $11
Current: $5.52
Upside: +99.46%
May 10, 2024
Downgrades: Sector Weight
Price Target: n/a
Current: $21.60
Upside: -
Oct 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $29.49
Upside: -
Sep 16, 2022
Initiates: Sector Weight
Price Target: n/a
Current: $7.01
Upside: -
Apr 16, 2021
Upgrades: Overweight
Price Target: $180 → $250
Current: $140.22
Upside: +78.29%